Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01886794 · ClinicalTrials.gov registry record · Phase 4
Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse
A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT01886794 is a Phase 4 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 7 participants.
The verdict
NCT01886794, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
Our primary aim in the current study is to determine important tissue differences, including muscle and connective tissue changes, between postmenopausal women and reproductive age women with pelvic floor dysfunction to help develop targeted and noninvasive treatments.
Interventions
- DRUG Postmenopausal, topical vaginal estrogen cream
- DRUG Placebo Comparator: Postmenopausal, topical placebo cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-06-06 |
| Est. Completion | 2023-12-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01886794
The ClinicalTrials.gov registry entry for NCT01886794 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Postmenopausal, topical vaginal estrogen cream is the first listed.
NCT01886794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01886794 about?
NCT01886794 is a clinical study titled "Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse". Our primary aim in the current study is to determine important tissue differences, including muscle and connective tissue changes, between postmenopausal women and reproductive age women with pelvic floor dysfunction to help develop targeted and noninvasive treatments.
What is the current status of trial NCT01886794?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2013-06-06. Estimated completion is 2023-12-11.
What interventions are being tested in trial NCT01886794?
The interventions under investigation include: Postmenopausal, topical vaginal estrogen cream (DRUG), Placebo Comparator: Postmenopausal, topical placebo cream (DRUG).
Who is sponsoring clinical trial NCT01886794?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.